8-KLeadership ChangesRegulation FD

QUEST DIAGNOSTICS INC 8-K Report, Executive Changes (Jun 24, 2020)

Filed June 24, 2020For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) has filed an 8-K report on June 24, 2020, detailing adjustments to its executive compensation plans in response to the COVID-19 pandemic. The Compensation Committee has added new 2020 performance goals under the Senior Management Incentive Plan (SMIP) and the broader Annual Incentive Plan. These new goals are designed to incentivize and recognize the company's critical role in the pandemic response, focusing on test development, capacity expansion, government collaboration, and partnerships for safe return-to-work programs. The adjustments reflect the company's commitment to aligning executive and employee compensation with strategic priorities, particularly those driven by the unprecedented circumstances of the COVID-19 pandemic. By incorporating these pandemic-related objectives alongside existing financial and operational metrics, Quest Diagnostics aims to motivate its leadership and workforce to effectively navigate the crisis and contribute to economic recovery and public health efforts. This proactive approach underscores the company's agility in adapting its compensation philosophy to evolving business needs and shareholder interests.

Key Highlights

  • 1Quest Diagnostics' Compensation Committee added new 2020 performance goals to its Senior Management Incentive Plan (SMIP) and Annual Incentive Plan.
  • 2These new goals are directly related to the company's response to the COVID-19 pandemic.
  • 3Key areas for the new performance goals include test development, capacity expansion, government collaboration, and partnerships for safe return-to-work.
  • 4The amendments aim to align executive and employee compensation with the company's strategic priorities during the pandemic.
  • 5The Compensation Committee also added a leadership component to the supplemental bonus opportunity under the SMIP.
  • 6These new performance goals will be assessed alongside previously established 2020 goals to determine incentive payouts.
  • 7All employees participating in the Annual Incentive Plan are now eligible for compensation based on these COVID-19 response goals.

Frequently Asked Questions

Quest Diagnostics adjusted its executive compensation plans to reflect the significant impact of the COVID-19 pandemic and the company's crucial role in responding to it. The changes aim to align incentive compensation with the company's efforts in areas such as COVID-19 testing and supporting safe return-to-work initiatives.

The new performance goals are tied to test development, expanding testing capacity, collaborating with government entities, and forming partnerships with public and private organizations to facilitate safe return-to-work programs and economic recovery.

While the new goals were initially detailed for the Senior Management Incentive Plan (SMIP) which includes executive officers, the company also announced that all employees participating in the Annual Incentive Plan will be eligible to receive incentive compensation based on these COVID-19 pandemic response goals.

The filing indicates that no other changes were made to the existing incentive programs applicable to executive officers. The new performance goals will be assessed in conjunction with the previously adopted 2020 goals.